» Articles » PMID: 38149098

The Role of the Hypothalamic-pituitary-adrenal Axis in Depression Across the Female Reproductive Lifecycle: Current Knowledge and Future Directions

Abstract

The aim of this narrative review is to consolidate knowledge on the role of the hypothalamic-pituitary-adrenal (HPA) axis in depression pathophysiology at different reproductive stages across the female lifespan. Despite growing evidence about the impact of gonadal hormones on mood disorders, no previous review has examined the interaction between such hormonal changes and the HPA axis within the context of depressive disorders in women. We will focus on HPA axis function in depressive disorders at different reproductive stages including the menstrual cycle (e.g., premenstrual dysphoric disorder [PMDD]), perinatally (e.g., postpartum depression), and in perimenopausal depression. Each of these reproductive stages is characterized by vast physiological changes and presents major neuroendocrine reorganization. The HPA axis is one of the main targets of such functional alterations, and with its key role in stress response, it is an etiological factor in vulnerable windows for depression across the female lifespan. We begin with an overview of the HPA axis and a brief summary of techniques for measuring HPA axis parameters. We then describe the hormonal milieu of each of these key reproductive stages, and integrate information about HPA axis function in depression across these reproductive stages, describing similarities and differences. The role of a history of stress and trauma exposure as a contributor to female depression in the context of HPA axis involvement across the reproductive stages is also presented. This review advances the pursuit of understanding common biological mechanisms across depressive disorders among women. Our overarching goal is to identify unmet needs in characterizing stress-related markers of depression in women in the context of hormonal changes across the lifespan, and to support future research in women's mental health as it pertains to pathophysiology, early diagnosis, and treatment targets.

Citing Articles

Editorial: Psychiatric illness across the menstrual cycle.

Hantsoo L, Osborne L, Susser L Front Psychiatry. 2025; 16:1568088.

PMID: 40012716 PMC: 11862688. DOI: 10.3389/fpsyt.2025.1568088.


Neuro-Nutrition and Exercise Synergy: Exploring the Bioengineering of Cognitive Enhancement and Mental Health Optimization.

Clemente-Suarez V, Martin-Rodriguez A, Curiel-Regueros A, Rubio-Zarapuz A, Tornero-Aguilera J Bioengineering (Basel). 2025; 12(2).

PMID: 40001727 PMC: 11851474. DOI: 10.3390/bioengineering12020208.


Development of a nomogram for predicting depression risk in patients with chronic kidney disease: an analysis of data from the US National Health and Nutrition Examination Survey, 2007-2014.

Lai R, Cheng J, Zhang T, Liang X, Zhu Y, Huang X BMJ Open. 2025; 15(2):e089956.

PMID: 39965947 PMC: 11836871. DOI: 10.1136/bmjopen-2024-089956.


A systematic review on the bidirectional relationship between trauma-related psychopathology and reproductive aging.

Arnold A, Prochaska T, Fickenwirth M, Powers A, Smith A, Chahine E J Mood Anxiety Disord. 2025; 8.

PMID: 39803367 PMC: 11721711. DOI: 10.1016/j.xjmad.2024.100082.


Psychological stress dysfunction in women with premenstrual syndrome.

Liu Q, Lin Y, Zhang W Heliyon. 2025; 10(22):e40233.

PMID: 39748962 PMC: 11693916. DOI: 10.1016/j.heliyon.2024.e40233.


References
1.
Schweizer-Schubert S, Gordon J, Eisenlohr-Moul T, Meltzer-Brody S, Schmalenberger K, Slopien R . Steroid Hormone Sensitivity in Reproductive Mood Disorders: On the Role of the GABA Receptor Complex and Stress During Hormonal Transitions. Front Med (Lausanne). 2021; 7:479646. PMC: 7873927. DOI: 10.3389/fmed.2020.479646. View

2.
Miller-Graff L, Cheng P . Consequences of violence across the lifespan: Mental health and sleep quality in pregnant women. Psychol Trauma. 2017; 9(5):587-595. DOI: 10.1037/tra0000252. View

3.
Sauer T, Sykes Tottenham L, Ethier A, Gordon J . Perimenopausal vasomotor symptoms and the cortisol awakening response. Menopause. 2020; 27(11):1322-1327. DOI: 10.1097/GME.0000000000001588. View

4.
Lommatzsch M, Hornych K, Zingler C, Schuff-Werner P, Hoppner J, Virchow J . Maternal serum concentrations of BDNF and depression in the perinatal period. Psychoneuroendocrinology. 2005; 31(3):388-94. DOI: 10.1016/j.psyneuen.2005.09.003. View

5.
Pochigaeva K, Druzhkova T, Yakovlev A, Onufriev M, Grishkina M, Chepelev A . Hair cortisol as a marker of hypothalamic-pituitary-adrenal Axis activity in female patients with major depressive disorder. Metab Brain Dis. 2017; 32(2):577-583. DOI: 10.1007/s11011-017-9952-0. View